(Q24242605)

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

Treatment of patent ductus arteriosus with ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Effects of indomethacin on cerebral haemodynamics in very preterm infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Determination of indomethacin and mefenamic acid in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Cyclooxygenase isoenzymes and patency of ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Localized intestinal perforation following intravenous indomethacin in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Ibuprofen treatment of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Systematic review: intravenous Ibuprofen in preterm newborns

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

[Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Back to the drawing board

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

Variations in practice and outcomes in the Canadian NICU network: 1996-1997.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB3

7 January 2021

10.1002/14651858.CD003481.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18254020

1 reference

Consolidated OpenCitations Corpus – April 2017